US Physicalrapy Inc (USPH)
Return on equity (ROE)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 31,424 | 22,836 | 25,462 | 28,875 | 28,239 | 30,190 | 30,493 | 30,769 | 32,158 | 39,764 | 40,216 | 41,457 | 40,831 | 43,648 | 44,555 | 42,351 | 35,194 | 30,093 | 28,224 | 32,612 |
Total stockholders’ equity | US$ in thousands | 488,929 | 482,758 | 484,572 | 479,771 | 476,194 | 491,971 | 488,498 | 318,058 | 315,793 | 317,146 | 307,177 | 300,971 | 295,606 | 289,783 | 283,848 | 276,184 | 276,160 | 264,919 | 255,254 | 241,064 |
ROE | 6.43% | 4.73% | 5.25% | 6.02% | 5.93% | 6.14% | 6.24% | 9.67% | 10.18% | 12.54% | 13.09% | 13.77% | 13.81% | 15.06% | 15.70% | 15.33% | 12.74% | 11.36% | 11.06% | 13.53% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $31,424K ÷ $488,929K
= 6.43%
The return on equity (ROE) of US Phystherapy Inc has shown fluctuating trends over the past few years. ROE ranged from 11.06% to 15.70% during the period from June 30, 2020, to June 30, 2021, indicating a relatively stable performance during that time.
However, starting from March 31, 2022, the ROE began to decline gradually, reaching a low of 4.73% on September 30, 2024, before recovering slightly to 6.43% by December 31, 2024. This downward trend in ROE could suggest challenges in utilizing shareholder equity effectively to generate profits.
The decreasing ROE may reflect issues related to profitability, efficiency, or leverage within the company. It is important for US Physicalrapy Inc to address these factors and implement strategies to improve ROE in order to enhance shareholder value and overall financial performance.
Peer comparison
Dec 31, 2024